GlaxoSmithKline’s Jerry Adams Joins Fox Chase as Visiting Professor

PHILADELPHIA (September 12, 2017) – Fox Chase Cancer Center is pleased to welcome Jerry Adams, PhD, director of Medicinal Chemistry, Immuno-Oncology, and Combinations at GlaxoSmithKline (GSK), as Visiting Professor. Adams will collaborate with several research teams, including those working on drug development and epigenetics.

Adams has more than 30 years of experience at GSK in a variety of roles. In recent years, he has guided the target selection strategy for immuno-oncology discovery chemistry, assisted in the evaluation of external opportunities, and acted as an advisor for immuno-oncology discovery research programs. In 2016 Adams was elected as a Senior Fellow in the newly created the GSK Fellows Program. Among many accomplishments, Adams is a renowned expert in the field of protein kinase inhibitors, and is an inventor on more than 45 U.S. patents.

“We look forward to all he will contribute in his professorship here,” said Erica Golemis, PhD, deputy chief science officer and co-leader of the Molecular Therapeutics program at Fox Chase. “There is a lot of enthusiasm among our faculty for a chance to work with Jerry and to build stronger bridges to GSK.”

Adams began his visiting professorship in late August.

“I am looking forward to working with the researchers at Fox Chase and learning how we can assist each other in our common goal of helping cancer patients live longer and feel better,” Adams said.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text